Patients with paramyotonia congenita show signs of myopathy with central nuclei, but normal muscle fiber distribution, capillarization, and biochemical markers compared to healthy controls.
Answers are grounded in this paper and cite their sources.
Should not yet alter management of paramyotonia congenita; leaves open the clinical relevance of central nuclei for progression and targeted studies.
In 12 patients with paramyotonia congenita, percutaneous needle biopsies from the brachial biceps muscle were performed. Muscle fibre area, distribution of muscle fibre types I, II-A and II-B and capillarization were not different from healthy controls. Signs of myopathy with central nuclei in the muscle cells were noted in 9 of the patients. 4 of these patients also had small areas with degeneration and, in one, vacuoles were observed. Quantitative determination of muscle glycogen, water and protein content were within normal range as were enzyme activities for hexokinase, lactate dehydrogenase, citrate synthetase and 3-hydroxy-acyl-CoA dehydrogenase.
No takes yet. Share an insight, caveat, or question.
Friis et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: